- Home
- EPOW vs ALGS Comparison
EPOW vs ALGS Comparison
Compare EPOW & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- ALGS
- Stock Information
- Founded
- EPOW 2014
- ALGS 2018
- Country
- EPOW China
- ALGS United States
- Employees
- EPOW N/A
- ALGS 68
- Industry
- EPOW Business Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- ALGS Health Care
- Exchange
- EPOW Nasdaq
- ALGS Nasdaq
- Market Cap
- EPOW 23.9M
- ALGS 71.0M
- IPO Year
- EPOW 2021
- ALGS 2020
- Fundamental
- Price
- EPOW $0.85
- ALGS $19.03
- Analyst Decision
- EPOW
- ALGS Strong Buy
- Analyst Count
- EPOW 0
- ALGS 1
- Target Price
- EPOW N/A
- ALGS $75.00
- AVG Volume (30 Days)
- EPOW 17.5K
- ALGS 562.3K
- Earning Date
- EPOW 11-29-2024
- ALGS 11-06-2024
- Dividend Yield
- EPOW N/A
- ALGS N/A
- EPS Growth
- EPOW N/A
- ALGS N/A
- EPS
- EPOW N/A
- ALGS N/A
- Revenue
- EPOW $45,050,405.00
- ALGS $5,997,000.00
- Revenue This Year
- EPOW N/A
- ALGS N/A
- Revenue Next Year
- EPOW N/A
- ALGS N/A
- P/E Ratio
- EPOW N/A
- ALGS N/A
- Revenue Growth
- EPOW 18.16
- ALGS N/A
- 52 Week Low
- EPOW $0.53
- ALGS $6.76
- 52 Week High
- EPOW $1.36
- ALGS $30.00
- Technical
- Relative Strength Index (RSI)
- EPOW 37.72
- ALGS 70.57
- Support Level
- EPOW $0.86
- ALGS $14.65
- Resistance Level
- EPOW $0.92
- ALGS $24.84
- Average True Range (ATR)
- EPOW 0.07
- ALGS 3.00
- MACD
- EPOW -0.01
- ALGS 0.59
- Stochastic Oscillator
- EPOW 0.05
- ALGS 56.96
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.